Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by John Ravits
Antisense Oligonucleotide Tofersen Distribution in the Central Nervous System of SOD1 -ALS Autopsy Tissue Donors
Antisense Oligonucleotide Tofersen Distribution in the Central Nervous System of SOD1-ALS Autopsy Tissue Donors Key Points Question What is the biodistribution of tofersen and its impact on SOD1 levels in human central nervous system tissues?
An emergent disease-associated motor neuron state precedes cell death in ALS
|
Keywords ALS neurodegeneration spinal cord motor neuron selective vulnerability snRNA-seq snATAC-seq spatial transcriptomics cell states microglial activation Introduction Amyotrophic lateral sclerosis (ALS) is a progressive disorder distinguished by degeneration of motor neurons in the brain and spinal cord. Motor neuron loss impairs mobility, dexterity, speech, and swallowing and ultimately causes fatal paralysis. ALS is a cruelly rapid disease.
By Olivia Gautier, Jacob Blum, Thao Nguyen Verified, Thảo Nguyen, Shaolong Cao, Sandy Klemm, Mai Yamakawa, Dann Huh, Jessica Hurt, Nasa Sinnott-Armstrong, Yi Zeng, Juliane Bombosch, Chang Liu, Lisa Encarnacion, Kevin A. Guttenplan, Derek Chen, Arwa Kathiria, Luke Zhao, Stephen Moore, Don W. Cleveland, John Ravits, Jessica Rexach, William J. Greenleaf, Aaron D. Gitler, Alex Meng, Kailee Ong
|
Cell Press
Verified
An emergent disease-associated motor neuron state precedes cell death in ALS
|
Introduction Amyotrophic lateral sclerosis (ALS) is a progressive disorder distinguished by degeneration of motor neurons in the brain and spinal cord. Motor neuron loss impairs mobility, dexterity, speech, and swallowing and ultimately causes fatal paralysis. ALS is a cruelly rapid disease. Most patients survive just 3 to 5 years after diagnosis.1 Effective therapies depend on defining the cellular and molecular drivers of motor neuron degeneration.
By Olivia Gautier, Jacob Blum, Thao Nguyen Verified, Thảo Nguyen, Shaolong Cao, Sandy Klemm, Mai Yamakawa, Dann Huh, Jessica Hurt, Nasa Sinnott-Armstrong, Yi Zeng, Juliane Bombosch, Chang Liu, Lisa Encarnacion, Kevin A. Guttenplan, Derek Chen, Arwa Kathiria, Luke Zhao, Stephen Moore, Alex Meng, Kailee Ong, Don W. Cleveland, John Ravits, Jessica Rexach, William J. Greenleaf, Aaron D. Gitler
|
Cell Press
Verified
Amyotrophic Lateral Sclerosis : A Review
Abstract Importance Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive weakness due to degeneration of upper motor neurons in the brain and lower motor neurons in the brainstem and spinal cord. It affects approximately 25 000 individuals in the United States.
Somatic mosaicism in ALS and FTD identifies focal mutations associated with widespread degeneration
|
Abstract Although mutations in many genes cause familial amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), most cases are sporadic (sALS and sFTD) with unclear etiology. Here we tested whether somatic mutations contribute to sALS and sFTD by deep targeted sequencing of 88 neurodegeneration-related genes in postmortem brain and spinal cord samples from 399 sporadic cases and 144 controls.
By Zinan Zhou, Junho Kim, August Yue Huang, Matthew Nolan, Junseok Park, Ryan Doan, Taehwan Shin, Michael Miller, Boxun Zhao, Jinhyeong Kim, Katherine Morillo, Rebecca C. Yeh, Connor J. Kenny, Jennifer Neil, Takuya Ohkubo, John Ravits, Olaf Ansorge, Lyle W. Ostrow, Clotilde Lagier-Tourenne, Eunjung Lee, Christopher Walsh, Mingyun Bae, Brian Chhouk, Chao-Zong Lee
|
Nature
Verified
Author Correction: Autoimmune response to C9orf72 protein in amyotrophic lateral sclerosis
|
Correction to: Nature https://doi.org/10.1038/s41586-025-09588-6 Published online 1 October 2025 In the version of the article initially published, Gregory P. Williams (Center for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA, USA) was missing from the author list and contributions and has now been added to the HTML and PDF versions of the article.
By Tanner Michaelis, Emil Johansson, April Frazier, Gregory Williams, James Berry, Merit E. Cudkowicz, Namita Goyal, Christina N. Fournier, Allison Snyder, Justin Kwan, Elizabeth Phillips, Simon A. Mallal, John Ravits, Karen S. Marder, John Sidney, David Sulzer, Alessandro Sette, Cecilia S. Lindestam Arlehamn, Jody Crook
|
Nature
Verified
An α2-Na/K ATPase/α-adducin complex in astrocytes triggers non-cell autonomous neurodegeneration
Abstract Perturbations of astrocytes trigger neurodegeneration in several diseases, but the glial cell–intrinsic mechanisms that induce neurodegeneration remain poorly understood. We found that a protein complex of α2-Na/K ATPase and α-adducin was enriched in astrocytes expressing mutant superoxide dismutase 1 (SOD1), which causes familial amyotrophic lateral sclerosis (ALS).
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with John
Contact John, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack